Compounds > 2,7-diaminomitosene
Page last updated: 2024-10-31

2,7-diaminomitosene and Animal Mammary Carcinoma

2,7-diaminomitosene has been researched along with Animal Mammary Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palom, Y2
Belcourt, MF2
Kumar, GS1
Arai, H1
Kasai, M1
Sartorelli, AC2
Rockwell, S2
Tomasz, M2
Tang, LQ1
Mehta, SS1
Pritsos, CA1
Pritsos, KL1

Other Studies

2 other studies available for 2,7-diaminomitosene and Animal Mammary Carcinoma

ArticleYear
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
    Oncology research, 1998, Volume: 10, Issue:10

    Topics: Animals; Chromatography, High Pressure Liquid; DNA Adducts; DNA Damage; Dose-Response Relationship,

1998
Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.
    Biochemical pharmacology, 2001, Jun-15, Volume: 61, Issue:12

    Topics: Animals; Biological Transport; Cell Division; Cell-Free System; Dicumarol; DNA Adducts; Drug Interac

2001